|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00648 SOFTMEDX-NEW
Nominal 
0.380 0.000 (0.000%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 54,639 | 6.426% | 51,340 | 33,765 | 1,699 | 9,617 |
| Cost of Sales | (36,241) | 19.944% | (30,215) | (20,028) | (909) | (4,392) |
| Gross Profit | 18,398 | -12.909% | 21,125 | 13,737 | 790 | 5,225 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (494) | (4,075) | (5,043) | |
| Profit / (Loss) on Disposal | -- | -- | (4,725) | -- | -- | 647 | |
| Other Non-operating Items | 311,413 | 1532.571% | 19,075 | (1,070) | 7,949 | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 327,954 | 2182.372% | 14,369 | (16,632) | (24,717) | (52,470) | |
| Taxation | (1,637) | -11.895% | (1,858) | (2,593) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | (1,558) | 1,624 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 326,317 | 2508.241% | 12,511 | (19,225) | (26,275) | (50,846) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 1,133 | -90.991% | 12,577 | 15,511 | 16,268 | 18,101 |
| Depreciation & Amortisation | 592 | -50.210% | 1,189 | 2,040 | 1,194 | 1,572 |
| Directors' Emoluments | -- | -- | 215 | 12,679 | 12,794 | 12,999 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Disclaimer | Disclaimer |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 100.000 | 2531.579% | 3.800 | -5.900 | -8.100 | -15.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.014) | (0.009) | (0.020) | (0.030) |
| NBV per share ($) | 0.008 | -- | (0.993) | (1.032) | (0.973) | (0.893) |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 326,317,000 |
| %Change | 2508.241% |
| EPS / (LPS) | HKD 1.000 |
| NBV Per Share ($) | HKD 0.008 |